🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Allogeneic hematopoietic stem cell transplantation (HTC) is the only curati...
Status
Unknown
Location
ICO- Hospital Germans Trias i Pujol
Start Date
2017-05-16
Trial ID
NCT03225417
Treatments Being Tested
The purpose of this study is to characterize the single-dose pharmacokineti...
Status
Completed
Location
Winship Cancer Institute, Emory University
Start Date
2013-09-16
Trial ID
NCT01830816
Treatments Being Tested
Multiple myeloma (MM) is the second most common hematologic malignancy with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-02
Trial ID
NCT06050512
Treatments Being Tested
A Phase IB/II Trial of Lenalidomide (Revlimid®), Ixazomib and Rituximab (RI...
Status
Terminated
Location
University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-02-20
Trial ID
NCT02898259
Treatments Being Tested
The purpose of this phase 1/2, open-label study was to evaluate the effect ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-27
Trial ID
NCT01335685
Treatments Being Tested
This research study is evaluating drugs called Millennium 9708 (referred to...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2016-01
Trial ID
NCT02582359
Treatments Being Tested
The main purpose of this study is to establish a safe and tolerable dose co...
Status
Withdrawn
Location
Columbia University Medical Center
Start Date
2020-11
Trial ID
NCT03880123
This is a phase I/II study of MLN9708 for the prophylaxis of chronic graft-...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2014-11-19
Trial ID
NCT02250300
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2017-03-06
Trial ID
NCT02942095
The purpose of this study is to provide continued access to ixazomib and/or...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-29
Trial ID
NCT01850524
Treatments Being Tested